Eric Schmidt FCA
Stock Analyst at Cantor Fitzgerald
(4.87)
# 327
Out of 4,966 analysts
44
Total ratings
53.5%
Success rate
84.7%
Average return
Main Sectors:
Stocks Rated by Eric Schmidt FCA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| POWL Powell Industries | Reiterated: Hold | $235 | $182.50 | +28.77% | 1 | Sep 2, 2026 | |
| DYN Dyne Therapeutics | Initiated Coverage: Buy | n/a | $18.21 | - | 1 | Jul 23, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | $206 | $217.15 | -5.13% | 4 | Jun 22, 2026 | |
| ODTX Odyssey Therapeutics | Initiated Coverage: Buy | n/a | $24.32 | - | 1 | Jun 2, 2026 | |
| LONA LeonaBio | Reiterated: Buy | n/a | $6.92 | - | 2 | Apr 7, 2026 | |
| GENB Generate Biomedicines | Initiated Coverage: Buy | n/a | $15.72 | - | 1 | Mar 24, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | n/a | $55.41 | - | 2 | Mar 19, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $75 → $74 | $18.64 | +297.00% | 4 | Dec 17, 2025 | |
| VSTM Verastem | Initiated Coverage: Buy | n/a | $7.32 | - | 1 | Oct 16, 2025 | |
| ALMS Alumis | Reiterated: Buy | n/a | $9.18 | n/a | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $72.44 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $4.95 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.55 | n/a | 8 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $37.36 | n/a | 1 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.87 | n/a | 2 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.62 | n/a | 3 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.60 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $19.62 | n/a | 1 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.05 | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $121.47 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $23.78 | n/a | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $33.14 | n/a | 1 | Nov 2, 2023 |
Powell Industries
Sep 2, 2026
Reiterated: Hold
Price Target: $235
Current: $182.50
Upside: +28.77%
Dyne Therapeutics
Jul 23, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $18.21
Upside: -
Biogen
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $206
Current: $217.15
Upside: -5.13%
Odyssey Therapeutics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $24.32
Upside: -
LeonaBio
Apr 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.92
Upside: -
Generate Biomedicines
Mar 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $15.72
Upside: -
Scholar Rock Holding
Mar 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $55.41
Upside: -
Legend Biotech
Dec 17, 2025
Reiterated: Buy
Price Target: $75 → $74
Current: $18.64
Upside: +297.00%
Verastem
Oct 16, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $7.32
Upside: -
Alumis
Aug 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $9.18
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $72.44
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $4.95
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $17.55
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $37.36
Upside: n/a
Jun 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.87
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.62
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $33.60
Upside: n/a
Mar 21, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $19.62
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $1.05
Upside: n/a
Apr 23, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $121.47
Upside: n/a
Apr 4, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $23.78
Upside: n/a
Nov 2, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $33.14
Upside: n/a